Dynamics of neutralizing antibodies against COVID-19 Omicron subvariants following breakthrough infection in southwest China between December 2022 and April 2024

Abstract From December 2022 to January 2023, the SARS-CoV-2 Omicron BA.5/BF.7 variant significantly impacted mainland China. While most COVID-19 patients experienced mild symptoms and were treated as outpatients or at home, some cases progressed to severe illness, necessitating hospitalization or ev...

Full description

Saved in:
Bibliographic Details
Main Authors: Yongquan He, Yi Yin, Yi Zhang, Huiping Yang, Zhiling Jiang, Fang Hao, Taiqiang Zhao, Xiaobin Liu, Yusong Liu, Yong Zeng, Xi Li, Xuemei Chen, Kaiju Xu, Chang Tan, Jie Yang, Li Jiang, Bo Gong, Zhenglin Yang
Format: Article
Language:English
Published: Nature Publishing Group 2025-07-01
Series:Signal Transduction and Targeted Therapy
Online Access:https://doi.org/10.1038/s41392-025-02319-3
Tags: Add Tag
No Tags, Be the first to tag this record!